Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function
- 1 August 1993
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 95 (2) , 161-168
- https://doi.org/10.1016/0002-9343(93)90256-o
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Management of Hypertensive CrisesPublished by American Medical Association (AMA) ,1991
- Treatment of Hypertensive CrisisNew England Journal of Medicine, 1990
- Selective dopamine-1 agonist therapy in severe hypertension: Effects of intravenous fenoldopamJournal of the American College of Cardiology, 1988
- Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam.Circulation, 1987
- Dopamine receptor agonists in cardiovascular therapyDrug Development Research, 1983
- Cyanide toxicity of sodium nitroprusside in therapeutic use with and without sodium thiosulphateJournal of Molecular Medicine, 1982
- Management of Malignant Hypertension Complicated by Renal InsufficiencyNew England Journal of Medicine, 1974
- Endogenous Creatinine Clearance as a Clinical Measure of Glomerular Filtration RateBMJ, 1971
- Functional impairment in chronic renal disease III. Studies of potassium excretionThe Lancet Healthy Longevity, 1971
- Cardiovascular Actions of Sodium Nitroprusside in Animals and Hypertensive PatientsCirculation, 1955